CMS Cites OM1 Led Outcomes Standardization Effort In Treatment Resistant Depression Memo
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
Showing 131-135 of 149 real-world data & outcomes research:
Applying AI for personalized treatment decisions and lowering costs in orthopedics
Becker’s Spine Review | Written by Richard Gliklich, MD, CEO, OM1 | November 26, 2018 In healthcare, results really matter Understanding why certain treatments and procedures work better on some patients and not so well on others is the key to delivering more personalized care and ultimately achieving better results for all stakeholders in the care process.[…]
New Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythm
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]
OM1 Lupus Registry Reaches More Than 25,000 Patients Prospectively Followed With Deep Clinical And Lab Data
OM1 LUPUS REGISTRY REACHES MORE THAN 25,000 PATIENTS PROSPECTIVELY FOLLOWED WITH DEEP CLINICAL AND LAB DATA Ready for collaborations, the registry enables faster, more cost-effective access to research-grade lupus data for better understanding, comparing, and predicting treatment outcomes BOSTON, October 17, 2018 — OM1, a leading health outcomes, registries and technology company creating solutions to[…]
Using Big Data Like Biomarkers to Advance Clinical Development & Commercialization
March 28, 2018 – 2 PM ET What if you could use predictive models like biomarkers to pre-emptively screen and more effectively target patients who are more likely to respond to your drug in trials and in practice? What if you could rapidly answer questions on comparative treatment outcomes and predict those most likely to[…]